-
公开(公告)号:US06514970B1
公开(公告)日:2003-02-04
申请号:US10149805
申请日:2002-06-13
申请人: Dashyant Dhanak , Steven David Knight , Gregory Lee Warren , Jian Jin , Katherine L. Widdowson , Richard McCulloch Keenan
发明人: Dashyant Dhanak , Steven David Knight , Gregory Lee Warren , Jian Jin , Katherine L. Widdowson , Richard McCulloch Keenan
IPC分类号: A61K315375
CPC分类号: C07D401/12 , C07D403/12 , C07D405/12 , C07D409/12 , C07D409/14
摘要: The present invention relates to pyrrolidiones, pharmaceutical compostions containing them and their use as antagonist of urotensin II.
摘要翻译: 本发明涉及吡咯烷酮,含有它们的药物组合物及其作为尿素调节素II拮抗剂的用途。
-
公开(公告)号:US06544992B1
公开(公告)日:2003-04-08
申请号:US10149793
申请日:2002-06-13
IPC分类号: A61K315377
CPC分类号: C07D401/10 , C07D207/14 , C07D211/56
摘要: The present invention relates to pyrrolyl and pyridyl derivatives, pharmaceutical compositions containing them and their use as inhibitors of urotensin II.
摘要翻译: 本发明涉及吡咯基和吡啶基衍生物,含有它们的药物组合物及其作为尿路保护素II抑制剂的用途。
-
公开(公告)号:US08329928B2
公开(公告)日:2012-12-11
申请号:US13349795
申请日:2012-01-13
申请人: Andrew McDonald , Gustave Bergnes , Bainian Feng , David J. Morgans, Jr. , Steven David Knight , Kenneth A. Newlander , Dashyant Dhanak , Christopher A. Brook
发明人: Andrew McDonald , Gustave Bergnes , Bainian Feng , David J. Morgans, Jr. , Steven David Knight , Kenneth A. Newlander , Dashyant Dhanak , Christopher A. Brook
IPC分类号: C07D311/22
CPC分类号: C07D405/06 , C07D311/22 , C07D311/36 , C07D405/12 , C07D407/12 , C07D409/12 , C07D413/12 , C07D417/12
摘要: Compounds useful for treating cellular proliferative diseases and disorders by modulating the activity of KSP are disclosed.
摘要翻译: 公开了通过调节KSP活性来治疗细胞增殖性疾病和病症的化合物。
-
公开(公告)号:US20110230550A1
公开(公告)日:2011-09-22
申请号:US13075076
申请日:2011-03-29
申请人: Andrew McDonald , Gustave Bergnes , Bainian Feng , David J. Morgans, JR. , Steven David Knight , Kenneth A. Newlander , Dashyant Dhanak , Christopher A. Brook
发明人: Andrew McDonald , Gustave Bergnes , Bainian Feng , David J. Morgans, JR. , Steven David Knight , Kenneth A. Newlander , Dashyant Dhanak , Christopher A. Brook
IPC分类号: A61K31/352 , A61P35/00
CPC分类号: C07D405/06 , C07D311/22 , C07D311/36 , C07D405/12 , C07D407/12 , C07D409/12 , C07D413/12 , C07D417/12
摘要: Compounds useful for treating cellular proliferative diseases and disorders by modulating the activity of KSP are disclosed.
摘要翻译: 公开了通过调节KSP活性来治疗细胞增殖性疾病和病症的化合物。
-
公开(公告)号:US20100216801A1
公开(公告)日:2010-08-26
申请号:US12281184
申请日:2007-03-02
IPC分类号: A61K31/497 , A61K31/4709 , A61P37/00 , A61P29/00 , A61P9/00 , A61P25/28 , A61P11/06 , A61P13/12 , A61P35/00 , A61P15/08 , A61P1/00 , A61P9/10
CPC分类号: A61K31/498
摘要: Invented is a method of inhibiting the activity/function of PI3 kinases using substituted thiazolones. Also invented is a method of treating one or more disease states selected from: autoimmune disorders, inflammatory diseases, cardiovascular diseases, neurodegenerative diseases, allergy, asthma, pancreatitis, multiorgan failure, kidney diseases, platelet aggregation, cancer, sperm motility, transplantation rejection, graft rejection and lung injuries by the administration of substituted thiazolones.
摘要翻译: 发明了使用取代的噻唑啉酮抑制PI3激酶活性/功能的方法。 还发明了一种治疗选自以下的一种或多种疾病状态的方法:自身免疫性疾病,炎性疾病,心血管疾病,神经变性疾病,变态反应,哮喘,胰腺炎,多器官功能衰竭,肾脏疾病,血小板聚集,癌症,精子活力,移植排斥反应, 通过施用取代的噻唑啉酮的移植物排斥和肺损伤。
-
公开(公告)号:US20100105767A1
公开(公告)日:2010-04-29
申请号:US12582424
申请日:2009-10-20
申请人: Andrew McDonald , Gustave Bergnes , Bainian Feng , David J. Morgan, JR. , Steven David Knight , Kenneth A. Newlander , Dashyant Dhanak , Christopher A. Brook
发明人: Andrew McDonald , Gustave Bergnes , Bainian Feng , David J. Morgan, JR. , Steven David Knight , Kenneth A. Newlander , Dashyant Dhanak , Christopher A. Brook
IPC分类号: A61K31/352 , A61P35/00
CPC分类号: C07D405/06 , C07D311/22 , C07D311/36 , C07D405/12 , C07D407/12 , C07D409/12 , C07D413/12 , C07D417/12
摘要: Compounds useful for treating cellular proliferative diseases and disorders by modulating the activity of KSP are disclosed.
摘要翻译: 公开了通过调节KSP活性来治疗细胞增殖性疾病和病症的化合物。
-
公开(公告)号:US20090215818A1
公开(公告)日:2009-08-27
申请号:US12374486
申请日:2007-07-24
IPC分类号: A61K31/4188 , C07D471/02
CPC分类号: C07D471/04 , A61K9/0019 , A61K9/2063 , A61K9/4858 , A61K47/10
摘要: Invented is a method of inhibiting the activity/function of PI3 kinases using thiozolidinedione derivatives. Also invented is a method of treating one or more disease states selected from: autoimmune disorders, inflammatory diseases, cardiovascular diseases, neurodegenerative diseases, allergy, asthma, pancreatitis, multiorgan failure, kidney diseases, platelet aggregation, cancer, sperm motility, transplantation rejection, graft rejection and lung injuries by the administration of thiozolidinedione derivatives.
摘要翻译: 发明了使用噻唑烷二酮衍生物抑制PI3激酶的活性/功能的方法。 还发明了一种治疗选自以下的一种或多种疾病状态的方法:自身免疫性疾病,炎性疾病,心血管疾病,神经变性疾病,变态反应,哮喘,胰腺炎,多器官功能衰竭,肾脏疾病,血小板聚集,癌症,精子活力,移植排斥反应, 通过施用噻唑烷二酮衍生物的移植物排斥和肺损伤。
-
公开(公告)号:US06924376B2
公开(公告)日:2005-08-02
申请号:US10412712
申请日:2003-04-11
申请人: Andrew McDonald , Gustave Bergnes , Bainian Feng , David J. Morgans, Jr. , Steven David Knight , Kenneth A. Newlander , Dashyant Dhanak , Christopher A. Brook
发明人: Andrew McDonald , Gustave Bergnes , Bainian Feng , David J. Morgans, Jr. , Steven David Knight , Kenneth A. Newlander , Dashyant Dhanak , Christopher A. Brook
IPC分类号: C07D233/02 , A61K31/337 , A61K31/352 , A61K31/36 , A61K31/381 , A61K31/4025 , A61K31/4155 , A61K31/4178 , A61K31/422 , A61K31/433 , A61K31/4433 , A61K45/00 , A61P9/00 , A61P9/10 , A61P29/00 , A61P31/10 , A61P35/00 , A61P37/00 , A61P43/00 , C07D311/22 , C07D311/36 , C07D405/06 , C07D405/12 , C07D407/12 , C07D409/12 , C07D413/12 , C07D417/12
CPC分类号: C07D405/06 , C07D311/22 , C07D311/36 , C07D405/12 , C07D407/12 , C07D409/12 , C07D413/12 , C07D417/12
摘要: Compounds useful for treating cellular proliferative diseases and disorders by modulating the activity of KSP are disclosed.
摘要翻译: 公开了通过调节KSP活性来治疗细胞增殖性疾病和病症的化合物。
-
公开(公告)号:US20120209012A1
公开(公告)日:2012-08-16
申请号:US13349795
申请日:2012-01-13
申请人: Andrew McDonald , Gustave Bergnes , Bainian Feng , David J. Morgans, JR. , Steven David Knight , Kenneth A. Newlander , Dashyant Dhanak , Christopher A. Brook
发明人: Andrew McDonald , Gustave Bergnes , Bainian Feng , David J. Morgans, JR. , Steven David Knight , Kenneth A. Newlander , Dashyant Dhanak , Christopher A. Brook
IPC分类号: C07D311/22
CPC分类号: C07D405/06 , C07D311/22 , C07D311/36 , C07D405/12 , C07D407/12 , C07D409/12 , C07D413/12 , C07D417/12
摘要: Compounds useful for treating cellular proliferative diseases and disorders by modulating the activity of KSP are disclosed.
摘要翻译: 公开了通过调节KSP活性来治疗细胞增殖性疾病和病症的化合物。
-
10.Modulation of KSP kinesin activity with heterocyclic-fused pyrimidinone derivatives 失效
标题翻译: 用杂环稠合嘧啶酮衍生物调节KSP驱动蛋白活性公开(公告)号:US07332498B2
公开(公告)日:2008-02-19
申请号:US11284806
申请日:2005-11-23
IPC分类号: A61K31/519 , A61K31/5025 , C07D471/04 , C07D487/04 , C07D498/04 , C07D211/78 , C07D211/82 , C07D211/70 , C07D211/90 , C07D211/72 , C07D211/84 , C07D213/84 , C07D213/72 , C07D213/78 , C07D213/46 , C07D213/56
CPC分类号: C07D471/04 , C07D475/02 , C07D487/04
摘要: A method of modulating KSP kinesin activity in vitro comprising contacting KSP kinesin with at least one chemical entity chosen from compounds represented by Formula I: and pharmaceutically acceptable salts thereof, where the variables are as defined further herein.
摘要翻译: 一种在体外调节KSP驱动蛋白活性的方法,包括使KSP驱动蛋白与至少一种选自式I表示的化合物的化学实体及其药学上可接受的盐接触,其中变量如本文进一步定义。
-
-
-
-
-
-
-
-
-